Preoperative Serum IL-12p40 Is a Potential Predictor of Kasai Portoenterostomy Outcome in Infants with Biliary Atresia

Table 1

Demographic, clinical, and laboratory characteristics of the studied patients.

Characteristics	BA; ()	Neglected BA; ()	Non-BA; ()	value
Age at liver biopsy (days)	56.56 ± 11.55	141.05 ± 60.69	57.60 ± 18.90	<0.0001
Male, n (%)	14 (56)	9 (45)	16 (53.3)	0.75
Clay stool	25 (100)	20 (100)	10 (33.3)	<0.0001
Hepatomegaly (US)	25 (100)	19 (95)	38 (93.3)	0.438
Splenomegaly (US)	16 (64)	16 (80)	16 (53.3)	0.157
Ascites (US)	0 (0.0)	4 (20)	1 (3.3)	0.018
Total bilirubin (mg/dl)	11.32 ± 4.1	12.12 ± 4.23	10.77 ± 4.75	0.424
Direct bilirubin (mg/dl)	7.74 ± 3.48	9.08 ± 3.92	7.72 ± 4.22	0.29
Alanine transaminase (U/l)	141.86 ± 129.95	149.2 ± 114.16	168.37 ± 112.91	0.465
Aspartate transaminase (U/l)	200.04 ± 129.69	274.15 ± 197.89	347.0 ± 258.97	0.058
Albumin (g/dl)	3.69 ± 0.46	3.23 ± 0.62	3.5 ± 0.69	0.11
Alkaline phosphatase (U/l)	568.68 ± 300.02	738.0 ± 349.57	725.37 ± 359.18	0.092
Gamma-glutamyl transpeptidase (U/l)	1066.28 ± 762.45	832.2 ± 634.82	223.53 ± 265.61	<0.0001
Prothrombin time (sec)	12.42 ± 1.65	14.36 ± 2.46	14.45 ± 6.73	0.017

BA: biliary atresia.